Navigation Links
Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea

rative colitis and Crohn's disease, and colon infections. Cosmo's first MMX(tm) product that has reached the market is LIALDA(tm) / MEZAVANT(tm), a treatment for IBD that is licensed globally to Giuliani and Shire Pharmaceuticals. Cosmo's proprietary MMX(tm) technology is at the core of the company's product pipeline and was developed from its expertise in formulating and manufacturing gastrointestinal drugs for international clients at its GMP (Good Manufacturing Practice) facilities in Lainate, Italy. For further information on Cosmo, please visit the Company's website: www.cosmopharmaceuticals.com

Contact:

Dr. Chris Tanner, CFO and Head of Investor Relations

Cosmo Pharmaceuticals SpA

Tel: +39 02 9333 7614

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Cosmo undertakes no obligation to publicly update or revise any forward-looking statements.

Claire Rowell Manager Financial Communications

Holborn Gate, 26 Southampton Buildings London, WC2A 1PB

T +44 (0)20 7269 7285 F +44 (0)20 7242 8695

www.fd.com

London, New York, Bahrain, Beijing, Boston, Cape Town, Chicago, Dubai, Dublin, Frankfurt, Hong Kong, Johannesburg, Manchester, Moscow, Paris, San Francisco, Stockholm and Washington.


'"/>




Page: 1 2

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
10. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
(Date:11/19/2009)...Newswire-Asia/ -- ScinoPharm, a leading global,sup... announced that its,Tainan facility has received t...ridge(R) Consultants, Inc. The Certification confi... safe handling of potent active,pharmaceutical ing...ies and,production areas used for the manufacturin...
(Date:11/19/2009)...wswire/ -- Ligon Discovery, Inc., which uses propr...d drugs against high-value targets, today announce...incTANK Ventures. The company will use the capital...ill screen over 100 high-value disease protein tar...al Partner Christian Bailey joins the board. ,,...
(Date:11/19/2009)...swire/ -- Breast-Specific Gamma Imaging/Molecular ...endorsed by two highly esteemed organizations for ...east Imaging (SBI) and the American College of Sur...g the further application of this breakthrough ima...cancer. ,, "These endorsements reinforce what I...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Sundia Welcomes Professional U S Delegation 14469 1Sundia Welcomes Professional U S Delegation 14469 2Beneficial effects of alcohol 3F 59447 1Beneficial effects of alcohol 3F 59447 2Cell study explains why younger people more at risk of vCJD 10351 1Cell study explains why younger people more at risk of vCJD 10351 2
(Date:11/22/2009)...YORK (Nov. 22 2009) -- Physician-scientists from W...ecular mechanism that may prove to be a powerful t... a type of cancer that affects lymphocytes, or whi...archers have been able to powerfully suppress tumo..., Promising results have led to the design of a c...
(Date:11/22/2009)... Man & Machine post You Tub...sus the competition , Lan...yboard users interested in learning what a really ...une into “Really Cool Keyboard vs Washable C... The film demonstrates how the premium, Really Coo...
(Date:11/21/2009)... , NEW YORK, Nov. 21 Milvia Lop...w York City, recently filed suit, in Supreme Court...e complaint alleges that while Ms. Lopez underwent...at ST. VINCENT,S HOSPITAL , doctors used an HIV i...plaint alleges that several hours after being disc...
(Date:11/21/2009)... Innovative medical apparel com...rence , San Clemente, Cal...ker of breakthrough medical apparel, today announc... display at Medica 2009, a leading international t...orf, Germany. Medelita inaugurates its men,s colle...
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understandin... 20 Dr. Jeremy Schmahma...ol and neurologist at the Massachusetts General Ho...ted his laboratory,s research on the new field of ...INDlink Foundation. ,, Dr. Schmahmann is an awa...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...oration and Roush Fenway Racing;,Launches New Inte...N, April 21 The American Red Cross,today announce...ampaign to,recruit NASCAR fans as blood donors and.../DC20034 ), Through the support of 3M and Roush ...
...rwin,Professional Underwriters, Inc. (Darwin) (NYS...e its first quarter 2008 financial results on Mond...the company,s first quarter,2008 financial results...ve webcast of Darwin,s earnings conference call ca...
...Pharmaceuticals, Inc. (Nasdaq: ISTA ), today anno... results on April 30, 2008, after the U.S. markets...imultaneous webcast, to,discuss these results at 4...nts may dial 617-597-5397. The,access code for the...
... their scalp or neck appear less likely to survive...other sites, according to a report in the April is...chives journals. , Melanoma rates continue to inc...g cancer prognosis has been debated for decades, t...
...ecisions on Bottom Line Return at 3rd Annual ... NEW YORK and LONDON, April 21 Dr. Andree Bates,p...ularis, will be,delivering a presentation on Makin...8-0421-ABates_72dpi.jpg) *(Photo Caption: Dr. And...
...isolate electrical impulses causing irregular hear...) -- Adding one step and no more than 20 seconds t... an operation to treat the common irregular heartb...ns at Washington University School of Medicine in ...
Other Medicine News:Health News:American Red Cross Launches National Campaign to Connect NASCAR Fans With Blood Donations 2Health News:American Red Cross Launches National Campaign to Connect NASCAR Fans With Blood Donations 3Health News:Darwin to Announce First Quarter 2008 Financial Results 2Health News:Survival rates appear lower for scalp and neck melanoma than for other sites 2Health News:Eularis to Address Making the Right Research Decision for ROI 2Health News:New Atrial Fibrillation Surgery Improves Results 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: